Does RITUXIMAB Cause Neoplasm malignant? 929 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 929 reports of Neoplasm malignant have been filed in association with RITUXIMAB (Rituxan). This represents 0.5% of all adverse event reports for RITUXIMAB.
929
Reports of Neoplasm malignant with RITUXIMAB
0.5%
of all RITUXIMAB reports
271
Deaths
203
Hospitalizations
How Dangerous Is Neoplasm malignant From RITUXIMAB?
Of the 929 reports, 271 (29.2%) resulted in death, 203 (21.9%) required hospitalization, and 21 (2.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 929 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
DENOSUMAB (698)
Which RITUXIMAB Alternatives Have Lower Neoplasm malignant Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE